Who
Sigurd Kirk
Director
Company insider
Files Form 4 as: Director, Assertio Holdings; Director, Aravive; Sr VP Finance & Corp Controlle, Barr Pharmaceuticals.
In numbers
- Trades disclosed
- 30
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 3
- Companies where not an officer
- 2
- First trade
- 26 Jul 2006
- Last trade
- 16 Jun 2026
- Last filed
- 16 Jun 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 16 Jun 2026filed 16 Jun 2026 | Assertio HoldingsBiotechnology | SEC FORM 4 Code U | —12,017 at $0.00 | filing |
| 16 Jun 2026filed 16 Jun 2026 | Assertio Holdingsoption or derivative · Biotechnology | SEC FORM 4 Code D | —7,913 | filing |
| 16 Jun 2026filed 16 Jun 2026 | Assertio Holdingsoption or derivative · Biotechnology | SEC FORM 4 Code D | —5,415 | filing |
| 16 Jun 2026filed 16 Jun 2026 | Assertio Holdingsoption or derivative | SEC FORM 4 Code D | —7,913 | filing |
| 16 Jun 2026filed 16 Jun 2026 | Assertio Holdingsoption or derivative | SEC FORM 4 Code D | —5,415 | filing |
| 16 Jun 2026filed 16 Jun 2026 | Assertio Holdingsoption or derivative | SEC FORM 4 Code D | —5,415 | filing |
| 16 Jun 2026filed 16 Jun 2026 | Assertio Holdingsoption or derivative · Biotechnology | SEC FORM 4 Code D | —5,415 | filing |
| 16 Jun 2026filed 16 Jun 2026 | Assertio Holdings | SEC FORM 4 Code U | —12,017 at $0.00 | filing |
| 5 May 2026filed 6 May 2026 | Assertio HoldingsBiotechnology | SEC FORM 4 Code A | —4,851 at $0.00 | filing |
| 5 May 2026filed 6 May 2026 | Assertio Holdings | SEC FORM 4 Code A | —4,851 at $0.00 | filing |
| 7 May 2025filed 9 May 2025 | Assertio Holdingsoption or derivative | SEC FORM 4 Code A | —81,225 at $0.00 | filing |
| 7 May 2025filed 9 May 2025 | Assertio Holdings | SEC FORM 4 Code A | —53,750 at $0.00 | filing |
| 23 May 2024filed 28 May 2024 | Assertio Holdingsoption or derivative | SEC FORM 4 Code A | —81,225 at $0.00 | filing |
| 23 May 2024filed 28 May 2024 | Assertio Holdings | SEC FORM 4 Code A | —53,750 at $0.00 | filing |
| 23 Sep 2022filed 26 Sep 2022 | Araviveoption or derivative | SEC FORM 4 Code A | —97,063 at $0.00 | filing |
| 10 Sep 2021filed 13 Sep 2021 | Araviveoption or derivative | SEC FORM 4 Code A | —22,812 at $0.00 | filing |
| 1 Jul 2021filed 2 Jul 2021 | Araviveoption or derivative | SEC FORM 4 Code A | —15,435 at $0.00 | filing |
| 1 Jul 2021filed 2 Jul 2021 | Araviveoption or derivative | SEC FORM 4 Code A | —5,245 at $0.00 | filing |
| 23 Dec 2008filed 29 Dec 2008 | Barr Pharmaceuticalsoption or derivative | SEC FORM 4 Code D | —1,500 | filing |
| 23 Dec 2008filed 29 Dec 2008 | Barr Pharmaceuticalsoption or derivative | SEC FORM 4 Code D | —3,000 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.
Related people
Nobody else traded the same names lately.